“…Immune-related mRNA (irmRNA) possess advantages over other mRNAs due to their crucial role in immune responses, specific expression in immune cells and tissues, differential expression patterns in response to immune stimuli or diseases, and potential as therapeutic targets. These features make immune-related mRNAs a valuable focus of research in immunology and provide opportunities for developing new diagnostic and therapeutic approaches for immune-related disorders [ [18] , [19] , [20] ]. The study conducted by Zhai et al suggest that differentially expressed irmRNAs (DEirmRNAs) could be potentially useful biomarkers for predicting prognosis and monitoring disease progression in patients with LUAD [ 21 ].…”